Compartilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Hematology, Transfusion and Cell Therapy
Hematological changes in SARS-COV-2 positive patients
Mafalda Urbano, Elísio Costa, Catarina Geraldes
10.1016/j.htct.2021.12.001
Hematol Transfus Cell Ther. 2022;44:218-24
Open access
Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis
Mohammadali Jafari, Seyed Alireza Dastgheib, Farzad Ferdosian, Hamid Mirjalili, Hossein Aarafi, Mahmood Noorishadkam, Mahta Mazaheri, Hossein Neamatzadeh
10.1016/j.htct.2021.09.020
Hematol Transfus Cell Ther. 2022;44:225-34
Open access
Dysregulation in erythrocyte dynamics caused by SARS-CoV-2 infection: possible role in shuffling the homeostatic puzzle during COVID-19
Michelle Mendanha Mendonça, Kellen Rosa da Cruz, Denise da Silva Pinheiro, Gean Carlos Alves Moraes, Patricia Maria Ferreira, Marcos Luiz Ferreira-Neto, Eduardo Sérgio da Silva, Reggiani Vilela Gonçalves, Gustavo Rodrigues Pedrino, James O. Fajemiroye, Carlos Henrique Xavier
10.1016/j.htct.2022.01.005
Hematol Transfus Cell Ther. 2022;44:235-45
Open access
COVID-19 induced follicular lymphoma remission
Renata Lyrio Baptista, Renata Moreira, Eduardo Rego
10.1016/j.htct.2022.01.017
Hematol Transfus Cell Ther. 2022;44:291-2
Open access
Prolonged viral shedding of SARS-CoV-2 in patients with acute leukemia
Milagros Altamirano-Molina, Iván Pacheco-Modesto, José Amado-Tineo
10.1016/j.htct.2021.11.017
Hematol Transfus Cell Ther. 2022;44:299-300
Open access
COVID-19 pandemic and blood transfusion services: The impact, response and preparedness experience of a tertiary care blood center in southern Karnataka, India
Dhivya Kandasamy, Shamee Shastry, Deepika Chenna, Ganesh Mohan
10.1016/j.htct.2021.09.019
Hematol Transfus Cell Ther. 2022;44:17-25
Open access
Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature
Bruno Almeida Costa, Kaiza Vilarinho da Luz, Sarah Emanuelle Viana Campos, Germison Silva Lopes, João Paulo de Vasconcelos Leitão, Fernando Barroso Duarte
10.1016/j.htct.2021.11.015
Hematol Transfus Cell Ther. 2022;44:26-31
Open access
Regarding management of COVID-19 in acute lymphoblastic leukemia
Mohammad Ammad Ud Din
10.1016/j.htct.2021.08.004
Hematol Transfus Cell Ther. 2022;44:120-1
Open access
Response to queries about “COVID-19 and adult acute lymphoblastic leukemia: Presentation and management”
Ayesha Butt, Natasha Ali
10.1016/j.htct.2021.08.009
Hematol Transfus Cell Ther. 2022;44:122-3
Open access
SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility
Roberto Crocchiolo, Francesco Alfarano, Elisabetta Volpato, Mariateresa Pugliano, Irene Cuppari, Anna Maria Mazza, Laura Bellio, Diana Fanti, Chiara Vismara, Francesco Scaglione, Nicoletta Sacchi, Simona Pollichieni, Lia Mele, Elisa Diral, Giovanni Grillo, Silvano Rossini
10.1016/j.htct.2021.09.017
Hematol Transfus Cell Ther. 2022;44:13-6
Open access
Conteúdo especial sobre COVID-19
- Prevalence of anti-HLA antibodies in COVID-19 convalescent plasma donors: an Indian experience
- 2 - Anuncio Acreditacao
- DOES PET/CT WITH 18F-FLUOROESTRADIOL (18F-FES) CONTRIBUTE TO THE ASSESSMENT OF BREAST CANCER COMPARED TO FLUORINE-2-D-DEOXYGLUCOSE (18F-FDG)?
- Anti-PF4 antibodies and their relationship with COVID infection
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.